Report Highlights
The global market for spinal surgical devices should grow from $10.0 billion in 2018 to $13.3 billion by 2023 at a compound annual growth rate (CAGR) of 5.8% from 2018 through 2023.
Report Includes
- 38 data tables and 15 additional tables
- Industry analysis of the global market for spinal surgical devices within the healthcare sector
- Analyses of the global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of technologies used for the treatment of spine injuries, including spinal decompression, fusion, non-fusion, vertebral compression fracture, minimally-invasive and spine biologics
- Information of growth driving factors like technological advancements in both surgical approaches and spinal implants, and restraints of the market
- Market analysis by surgical procedure, including annual incidence, trend analysis, and factors influencing future predicted surgical volume
- Insight into new products and technologies, as well as the development of new products that can address a growing number of therapeutic indications
- International regulations of spinal surgical devices and instruments
- Company profiles of key device manufacturers along with their market share and product strategies. Major players including Integra LifeSciences Holdings Corp., K2M Inc., Medtronic, SpineVision SA, Stryker Corp., and Zimmer Biomet
Report Scope
This report is a business analysis that has the primary purpose of examining trends and highlighting current and future potential in the market for spinal surgical devices. Detailed analysis of the competitive environment and technological development is provided in the report.
The report includes current and new technologies, market projections and the market shares of key market players. Market drivers, trends and potential regional market opportunities for spinal surgical devices are also identified in this report. This is an update from the previous version of this report and the analysis of clinical trials, presence of key players in respective spinal surgical segments and key developments are some of the additions.
The report includes sections on the following topics:
- Current prevalence of common spinal problems, trend analysis, and factors influencing future incidence.
- Global demand by device and projected future trends by device category.
- Risk factors and other drivers that might affect the future incidence of spine surgery and related utilization of spinal surgical devices.
- International regulation of spinal devices.
- Analysis of clinical trials.
- Market share and information on key device manufacturers.
This report includes market estimates for spinal surgical devices (fusion, non-fusion, decompression, and Vertebral Fracture Repair). Geographic market segmentation (North America, Europe, Asia-Pacific, Rest of World) of the overall market and global market share by company is provided. For market estimates, data has been provided for the year 2017, as the base year, 2018 and a forecast for 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant US dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Advanced Materials for Extreme Environments: Global Markets (AVM198B)
- Rare Disease Diagnostics: Technologies and Global Markets (PHM227B)
- Breakthrough Therapies: Market Dynamics and Investment Opportunities (PHM176B)
- Green Hydrogen: Global Markets (ENV060B)
- Softgel Capsules: Global Markets (PHM244B)
Report Highlights
-
The global spinal surgical market is projected to reach almost $6.5 billion by 2015, a 3.4% compound annual growth rate (CAGR) over the 2010 value of $5.5 billion.
-
The nonfusion device segment is expected to grow at a 10% compound annual growth rate (CAGR) versus 1.3% for fusion products, but it is not expected to constitute more than 15% of the total spinal surgical device market by 2015. This sector is valued at $624 million in 2010 and is expected to reach $1 billion by 2015.
-
Vertebral repair is a rapidly growing market, directly related to the continued growth of the aging population and osteoporosis-related fractures. This sector is valued at $532 million in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $858 million in 2015.
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Operating Room Equipment and Software: Global Markets
The global market for operating room equipment and software reached $26.1 billion in 2022. The market is estimated to increase from $27.8 billion in 2023 to reach $38.9 billion by 2028, at a compound annual growth rate (CAGR) of 6.9% from 2023 through 2028.
Advanced Orthopedic Technologies, Implants and Regenerative Products
The global market for advanced orthopedic technologies, implants, and regenerative products is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028, at a compound annual growth rate (CAGR) of 4.1% from 2023 through 2028.
Surgical Navigation Systems: Technologies and Global Markets
The global market for surgical navigation systems is estimated to increase from $1.2 billion in 2022 to reach over $1.8 billion by 2027, at a compound annual growth rate (CAGR) of 9.0% from 2022 through 2027.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More